微生物操纵者:Fusobacterium nucleatum调节结直肠癌中的瘤免疫微环境
Qian Li1, Wanyi Luo1,2, Li Xiao1,2
1State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, P.R. China.
Journal of oral microbiology
|August 7, 2025
概括
一种口腔细菌Fusobacterium nucleatum通过抑制瘤免疫微环境 (TiME) 来促进结直肠癌 (CRC). 这影响了CRC的进展和免疫疗法的有效性,突出了新的治疗点.
科学领域:
- 微生物学 微生物学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 杆菌核酸菌是一种口腔病原体,与牙周炎和结直肠癌 (CRC) 有关.
- 它在CRC瘤发生中的作用已经确立,最近的重点是它对瘤免疫微环境 (TiME) 的影响.
研究的目的:
- 审查Fusobacterium nucleatum如何与TiME中的免疫细胞相互作用.
- 总结其对CRC进展和免疫治疗的影响.
- 整合分子病理流行病学 (MPE) 的见解,并确定研究缺口.
主要方法:
- 文献综述综合了关于F.核和CRC的当前研究.
- 对F. nucleatum与TiME内的免疫细胞相互作用的分析.
- 整合MPE原则以了解宿主-微生物-环境动态.
主要成果:
- 核菌通过与免疫细胞相互作用,促进一种免疫抑制的TiME.
- 这种抑制降低了抗瘤免疫力,促进了CRC的发展.
- F. nucleatum会对CRC免疫疗法的疗效产生负面影响.
结论:
- F. nucleatum通过调节TiME在CRC进展和免疫疗法耐药性方面发挥着重要作用.
- 了解这些相互作用对于开发新的治疗策略至关重要.
- 需要进一步的研究来探索CRC中的宿主-微生物-环境相互作用.
更多相关视频
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
11.2K
08:42Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
576
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
